These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 30446352

  • 1. Does the Addition of Vasopressin to Catecholamine Vasopressors Affect Outcomes in Patients With Distributive Shock?
    Roumpf SK, Hunter BR.
    Ann Emerg Med; 2019 Jul; 74(1):153-155. PubMed ID: 30446352
    [No Abstract] [Full Text] [Related]

  • 2. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.
    McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, Lamontagne F, Healey JS, Whitlock RP, Belley-Côté EP.
    JAMA; 2018 May 08; 319(18):1889-1900. PubMed ID: 29801010
    [Abstract] [Full Text] [Related]

  • 3. [Vasopressin in distributive shock : Brief summary of the guidelines of the Canadian Critical Care Society published in December 2019].
    Bayerl S, Wöhrle T, Kilger E.
    Anaesthesist; 2020 Mar 08; 69(3):159-161. PubMed ID: 32055884
    [Abstract] [Full Text] [Related]

  • 4. The effect of early vasopressin use on patients with septic shock: A systematic review and meta-analysis.
    Huang H, Wu C, Shen Q, Xu H, Fang Y, Mao W.
    Am J Emerg Med; 2021 Oct 08; 48():203-208. PubMed ID: 33975132
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ, Cadiz ML, Natavio AM.
    Ann Pharmacother; 2020 Mar 08; 54(3):213-218. PubMed ID: 31625395
    [Abstract] [Full Text] [Related]

  • 6. Vasopressin versus norepinephrine infusion in patients with septic shock.
    Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, VASST Investigators.
    N Engl J Med; 2008 Feb 28; 358(9):877-87. PubMed ID: 18305265
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies.
    Heavner MS, McCurdy MT, Mazzeffi MA, Galvagno SM, Tanaka KA, Chow JH.
    J Intensive Care Med; 2021 Jun 28; 36(6):635-645. PubMed ID: 32223515
    [Abstract] [Full Text] [Related]

  • 8. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD, Jung R, Fish DN, MacLaren R.
    Ann Pharmacother; 2004 Jun 28; 38(7-8):1117-22. PubMed ID: 15178740
    [Abstract] [Full Text] [Related]

  • 9. [Vasopressin for treatment of hemodynamic disorders].
    Adukauskiene D, Sirvinskas E, Kevelaitis E.
    Medicina (Kaunas); 2008 Jun 28; 44(2):167-73. PubMed ID: 18344670
    [Abstract] [Full Text] [Related]

  • 10. Vasopressin infusion in children with catecholamine-resistant septic shock.
    Vasudevan A, Lodha R, Kabra SK.
    Acta Paediatr; 2005 Mar 28; 94(3):380-3. PubMed ID: 16028663
    [Abstract] [Full Text] [Related]

  • 11. Clinical review: Vasopressin and terlipressin in septic shock patients.
    Delmas A, Leone M, Rousseau S, Albanèse J, Martin C.
    Crit Care; 2005 Apr 28; 9(2):212-22. PubMed ID: 15774080
    [Abstract] [Full Text] [Related]

  • 12. Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock?
    Sandifer JP, Jones AE.
    Ann Emerg Med; 2013 Nov 28; 62(5):534-535. PubMed ID: 23683544
    [No Abstract] [Full Text] [Related]

  • 13. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
    Jia L, Wang P, Li C, Xie J.
    Shock; 2023 Dec 01; 60(6):746-752. PubMed ID: 37548686
    [Abstract] [Full Text] [Related]

  • 14. New evidence for old therapies in catecholamine-dependent septic shock.
    Friedrich JO, Lapinsky SE.
    Intensive Care Med; 2001 Apr 01; 27(4):787-90. PubMed ID: 11398711
    [No Abstract] [Full Text] [Related]

  • 15. The role of vasopressin in vasodilatory septic shock.
    Obritsch MD, Bestul DJ, Jung R, Fish DN, MacLaren R.
    Pharmacotherapy; 2004 Aug 01; 24(8):1050-63. PubMed ID: 15338853
    [Abstract] [Full Text] [Related]

  • 16. Vasopressin for vasopressor-dependent septic shock.
    Szumita PM, Enfanto CM, Greenwood B, Wechsler ME.
    Am J Health Syst Pharm; 2005 Sep 15; 62(18):1931-6. PubMed ID: 16141113
    [No Abstract] [Full Text] [Related]

  • 17. Role of vasopressin in the management of septic shock.
    Mutlu GM, Factor P.
    Intensive Care Med; 2004 Jul 15; 30(7):1276-91. PubMed ID: 15103461
    [Abstract] [Full Text] [Related]

  • 18. Low-dose vasopressin in the treatment of vasodilatory septic shock.
    Malay MB, Ashton RC, Landry DW, Townsend RN.
    J Trauma; 1999 Oct 15; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
    [Abstract] [Full Text] [Related]

  • 19. Renal Outcomes of Vasopressin and Its Analogs in Distributive Shock: A Systematic Review and Meta-Analysis of Randomized Trials.
    Nedel WL, Rech TH, Ribeiro RA, Pellegrini JAS, Moraes RB.
    Crit Care Med; 2019 Jan 15; 47(1):e44-e51. PubMed ID: 30303842
    [Abstract] [Full Text] [Related]

  • 20. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST, Shah P, Hollands JM, Shah RA, Shannon WD, Kollef MH.
    Surg Infect (Larchmt); 2007 Apr 15; 8(2):189-200. PubMed ID: 17437364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.